{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:15:48Z","timestamp":1780103748099,"version":"3.54.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010447","name":"German Center for Cardiovascular Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014386","name":"Abbott Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014386","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Prevencio"},{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The accurate identification of patients with high cardiovascular risk in suspected myocardial infarction (MI) is an unmet clinical need. Therefore, we sought to investigate the prognostic utility of a multi-biomarker panel with 29 different biomarkers in in 748 consecutive patients with symptoms indicative of MI using a machine learning-based approach.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Incident major cardiovascular events (MACE) were documented within 1\u00a0year after the index admission. The selection of the best multi-biomarker model was performed using the least absolute shrinkage and selection operator (LASSO). The independent and additive utility of selected biomarkers was compared to a clinical reference model and the Global Registry of Acute Coronary Events (GRACE) Score, respectively. Findings were validated using internal cross-validation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Median age of the study population was 64\u00a0years. At 1\u00a0year of follow-up, 160 cases of incident MACE were documented. 16 of the investigated 29 biomarkers were significantly associated with 1-year MACE. Three biomarkers including NT-proBNP (HR per SD 1.24), Apolipoprotein A-I (Apo A-I; HR per SD 0.98) and kidney injury molecule-1 (KIM-1; HR per SD 1.06) were identified as independent predictors of 1-year MACE. Although the discriminative ability of the selected multi-biomarker model was rather moderate, the addition of these biomarkers to the clinical reference model and the GRACE score improved model performances markedly (\u2206C-index 0.047 and 0.04, respectively).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>NT-proBNP, Apo A-I and KIM-1 emerged as strongest independent predictors of 1-year MACE in patients with suspected MI. Their integration into clinical risk prediction models may improve personalized risk stratification.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                <jats:p>Prognostic utility of a multi-biomarker approach in suspected myocardial infarction. In a cohort of 748 patients with symptoms indicative of myocardial infarction (MI) to the emergency department, we measured a 29-biomarker panel and performed regressions, machine learning (ML)-based variable selection and discriminative\/reclassification analyses. We identified three biomarkers as top predictors for 1-year major adverse cardiovascular events (MACE). Their integration into a clinical risk prediction model and the Global Registry of Acute Coronary Events (GRACE) Score allowed for marked improvement in discrimination and reclassification for 1-year MACE. <jats:italic>Apo<\/jats:italic> apolipoprotein; <jats:italic>CRP<\/jats:italic> C-reactive protein; <jats:italic>CRS<\/jats:italic> clinical risk score; <jats:italic>ECG<\/jats:italic> electrocardiogram; <jats:italic>EN-RAGE<\/jats:italic> extracellular newly identified receptor for advanced glycation end-products binding protein; <jats:italic>FABP<\/jats:italic> fatty acid\u2013binding protein; <jats:italic>GS<\/jats:italic> Grace Score; <jats:italic>hs-cTnI<\/jats:italic> high-sensitivity cardiac troponin I; <jats:italic>KIM-1<\/jats:italic> kidney injury molecule\u20131; <jats:italic>LASSO<\/jats:italic> least absolute shrinkage and selection operator; <jats:italic>MACE<\/jats:italic> major adverse cardiovascular events; <jats:italic>MI<\/jats:italic> myocardial infarction; <jats:italic>NRI<\/jats:italic> net reclassification improvement; <jats:italic>NT-proBNP<\/jats:italic> N-terminal prohormone of brain natriuretic peptide.<\/jats:p>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00392-023-02345-7","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T13:02:11Z","timestamp":1702299731000},"page":"1682-1691","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prognostic utility of a multi-biomarker panel in patients with suspected myocardial infarction"],"prefix":"10.1007","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5233-0680","authenticated-orcid":false,"given":"Bet\u00fcl","family":"Toprak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Weimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Lehmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Haller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tau S.","family":"Hartikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Schock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahir","family":"Karakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Renn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Twerenbold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils A.","family":"S\u00f6rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Westermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes T.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,11]]},"reference":[{"issue":"4","key":"2345_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ccl.2005.08.011","volume":"23","author":"AL Blomkalns","year":"2005","unstructured":"Blomkalns AL, Gibler WB (2005) Chest pain unit concept: rationale and diagnostic strategies. Cardiol Clin 23(4):411\u2013421","journal-title":"Cardiol Clin"},{"key":"2345_CR2","first-page":"1","volume":"43","author":"FA Bhuiya","year":"2010","unstructured":"Bhuiya FA, Pitts SR, McCaig LF (2010) Emergency department visits for chest pain and abdominal pain: United States, 1999\u20132008. NCHS Data Brief 43:1\u20138","journal-title":"NCHS Data Brief"},{"issue":"3","key":"2345_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet JP et al (2016) 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 37(3):267\u2013315","journal-title":"Eur Heart J"},{"issue":"14","key":"2345_CR4","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"JP Collet","year":"2020","unstructured":"Collet JP, Thiele H, Barbato E et al (2020) ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 42(14):1289\u20131367","journal-title":"Eur Heart J"},{"issue":"1","key":"2345_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.annemergmed.2015.11.013","volume":"68","author":"C Mueller","year":"2016","unstructured":"Mueller C, Giannitsis E, Christ M et al (2016) Multicenter evaluation of a 0-hour\/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T. Ann Emerg Med 68(1):76-87.e4","journal-title":"Ann Emerg Med"},{"issue":"3","key":"2345_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174288","volume":"12","author":"JT Neumann","year":"2017","unstructured":"Neumann JT, Sorensen NA, Ojeda F et al (2017) Early diagnosis of acute myocardial infarction using high-sensitivity troponin I. PLoS ONE 12(3):e0174288","journal-title":"PLoS ONE"},{"issue":"10151","key":"2345_CR7","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0140-6736(18)31996-2","volume":"392","author":"S Blankenberg","year":"2018","unstructured":"Blankenberg S, Neumann JT, Westermann D (2018) Diagnosing myocardial infarction: a highly sensitive issue. Lancet (London, England) 392(10151):893\u2013894","journal-title":"Lancet (London, England)"},{"issue":"8","key":"2345_CR8","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrcardio.2017.48","volume":"14","author":"D Westermann","year":"2017","unstructured":"Westermann D, Neumann JT, S\u00f6rensen NA, Blankenberg S (2017) High-sensitivity assays for troponin in patients with cardiac disease. Nat Rev Cardiol 14(8):472\u2013483","journal-title":"Nat Rev Cardiol"},{"issue":"8","key":"2345_CR9","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1373\/clinchem.2010.160192","volume":"57","author":"M Karakas","year":"2011","unstructured":"Karakas M, Januzzi JL Jr, Meyer J et al (2011) Copeptin does not add diagnostic information to high-sensitivity troponin T in low- to intermediate-risk patients with acute chest pain: results from the rule out myocardial infarction by computed tomography (ROMICAT) study. Clin Chem 57(8):1137\u20131145","journal-title":"Clin Chem"},{"issue":"9","key":"2345_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2217\/bmm-2019-0584","volume":"14","author":"JT Neumann","year":"2020","unstructured":"Neumann JT, S\u00f6rensen NA, Zeller T et al (2020) Application of a machine learning-driven, multibiomarker panel for prediction of incident cardiovascular events in patients with suspected myocardial infarction. Biomark Med 14(9):775\u2013784","journal-title":"Biomark Med"},{"issue":"1","key":"2345_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.amjcard.2017.03.265","volume":"120","author":"CP McCarthy","year":"2017","unstructured":"McCarthy CP, van Kimmenade RRJ, Gaggin HK et al (2017) Usefulness of multiple biomarkers for predicting incident major adverse cardiac events in patients who underwent diagnostic coronary angiography (from the catheter sampled blood archive in cardiovascular diseases [CASABLANCA] study). Am J Cardiol 120(1):25\u201332","journal-title":"Am J Cardiol"},{"issue":"3","key":"2345_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","volume":"40","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS et al (2018) Fourth universal definition of myocardial infarction. Eur Heart J 40(3):237\u2013269","journal-title":"Eur Heart J"},{"issue":"8","key":"2345_CR13","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.jacc.2021.06.027","volume":"78","author":"JT Neumann","year":"2021","unstructured":"Neumann JT, Weimann J, S\u00f6rensen NA et al (2021) A biomarker model to distinguish types of myocardial infarction and injury. J Am Coll Cardiol 78(8):781\u2013790","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2345_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15(4):361\u2013387","journal-title":"Stat Med"},{"issue":"22","key":"2345_CR15","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1001\/jama.291.22.2727","volume":"291","author":"KA Eagle","year":"2004","unstructured":"Eagle KA, Lim MJ, Dabbous OH et al (2004) A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 291(22):2727\u20132733","journal-title":"JAMA"},{"issue":"1","key":"2345_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/sim.4085","volume":"30","author":"MJ Pencina","year":"2011","unstructured":"Pencina MJ, D\u2019Agostino RB Sr, Steyerberg EW (2011) Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 30(1):11\u201321","journal-title":"Stat Med"},{"issue":"4","key":"2345_CR17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2217\/bmm.16.7","volume":"10","author":"JT Neumann","year":"2016","unstructured":"Neumann JT, Sorensen NA, Westermann D (2016) Biomarkers in the triage of chest pain: are we making progress? Biomark Med 10(4):345\u2013347","journal-title":"Biomark Med"},{"issue":"19","key":"2345_CR18","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1093\/eurheartj\/ehl153","volume":"27","author":"E Cavusoglu","year":"2006","unstructured":"Cavusoglu E, Ruwende C, Chopra V et al (2006) Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J 27(19):2300\u20132309","journal-title":"Eur Heart J"},{"key":"2345_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-2261-8-34","volume":"8","author":"T Br\u00fcgger-Andersen","year":"2008","unstructured":"Br\u00fcgger-Andersen T, P\u00f6nitz V, Staines H, Pritchard D, Grundt H, Nilsen DW (2008) B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: a prognostic study. BMC Cardiovasc Disord 8:34","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"2345_CR20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/joim.12183","volume":"277","author":"Y Devaux","year":"2015","unstructured":"Devaux Y, Mueller M, Haaf P et al (2015) Diagnostic and prognostic value of circulating microRNAs in patients with acute chest pain. J Intern Med 277(2):260\u2013271","journal-title":"J Intern Med"},{"issue":"8","key":"2345_CR21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.amjmed.2011.02.035","volume":"124","author":"P Haaf","year":"2011","unstructured":"Haaf P, Balmelli C, Reichlin T et al (2011) N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction. Am J Med 124(8):731\u2013739","journal-title":"Am J Med"},{"issue":"11","key":"2345_CR22","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1177\/2047487315619733","volume":"23","author":"\u00d8R Mjelva","year":"2016","unstructured":"Mjelva \u00d8R, P\u00f6nitz V, Br\u00fcgger-Andersen T, Grundt H, Staines H, Nilsen DW (2016) Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome. Eur J Prev Cardiol 23(11):1130\u20131140","journal-title":"Eur J Prev Cardiol"},{"issue":"6","key":"2345_CR23","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/joim.12756","volume":"283","author":"C Magnussen","year":"2018","unstructured":"Magnussen C, Blankenberg S (2018) Biomarkers for heart failure: small molecules with high clinical relevance. J Intern Med 283(6):530\u2013543","journal-title":"J Intern Med"},{"issue":"22","key":"2345_CR24","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1161\/CIRCULATIONAHA.109.884866","volume":"120","author":"E Di Angelantonio","year":"2009","unstructured":"Di Angelantonio E, Chowdhury R, Sarwar N et al (2009) B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation 120(22):2177\u20132187","journal-title":"Circulation"},{"issue":"4","key":"2345_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035059","volume":"7","author":"AM Mingels","year":"2012","unstructured":"Mingels AM, Joosen IA, Versteylen MO et al (2012) High-sensitivity cardiac troponin T: risk stratification tool in patients with symptoms of chest discomfort. PLoS ONE 7(4):e35059","journal-title":"PLoS ONE"},{"issue":"1","key":"2345_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL et al (2020) 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 41(1):111\u2013188","journal-title":"Eur Heart J"},{"issue":"34","key":"2345_CR27","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren FLJ, Mach F, Smulders YM et al (2021) 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 42(34):3227\u20133337","journal-title":"Eur Heart J"},{"issue":"16","key":"2345_CR28","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/0002-9149(92)91215-P","volume":"69","author":"G Sigurdsson","year":"1992","unstructured":"Sigurdsson G, Baldursdottir A, Sigvaldason H, Agnarsson U, Thorgeirsson G, Sigfusson N (1992) Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men. Am J Cardiol 69(16):1251\u20131254","journal-title":"Am J Cardiol"},{"issue":"17","key":"2345_CR29","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/j.jacc.2019.01.073","volume":"73","author":"P Natarajan","year":"2019","unstructured":"Natarajan P, Collier TS, Jin Z et al (2019) Association of an HDL apolipoproteomic score with coronary atherosclerosis and cardiovascular death. J Am Coll Cardiol 73(17):2135\u20132145","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2345_CR30","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.jacc.2010.11.025","volume":"57","author":"MH Davidson","year":"2011","unstructured":"Davidson MH (2011) Apolipoprotein A-I therapy promise, challenges, and disappointment. J Am Coll Cardiol 57(9):1120\u20131121","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2345_CR31","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2215\/CJN.08560816","volume":"12","author":"M Park","year":"2017","unstructured":"Park M, Hsu CY, Go AS et al (2017) Urine kidney injury biomarkers and risks of cardiovascular disease events and all-cause death: the CRIC study. Clin J Am Soc Nephrol: CJASN 12(5):761\u2013771","journal-title":"Clin J Am Soc Nephrol: CJASN"},{"issue":"18","key":"2345_CR32","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1136\/hrt.2010.220988","volume":"97","author":"C Meune","year":"2011","unstructured":"Meune C, Drexler B, Haaf P et al (2011) The GRACE score\u2019s performance in predicting in-hospital and 1-year outcome in the era of high-sensitivity cardiac troponin assays and B-type natriuretic peptide. Heart (British Cardiac Society) 97(18):1479\u20131483","journal-title":"Heart (British Cardiac Society)"},{"issue":"7","key":"2345_CR33","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1001\/jama.284.7.835","volume":"284","author":"EM Antman","year":"2000","unstructured":"Antman EM, Cohen M, Bernink PJ et al (2000) The TIMI risk score for unstable angina\/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 284(7):835\u2013842","journal-title":"JAMA"},{"issue":"16","key":"2345_CR34","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1161\/CIRCULATIONAHA.118.036426","volume":"138","author":"AR Chapman","year":"2018","unstructured":"Chapman AR, Hesse K, Andrews J et al (2018) High-sensitivity cardiac troponin I and clinical risk scores in patients with suspected acute coronary syndrome. Circulation 138(16):1654\u20131665","journal-title":"Circulation"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02345-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-023-02345-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02345-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T14:03:28Z","timestamp":1732111408000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-023-02345-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,11]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["2345"],"URL":"https:\/\/doi.org\/10.1007\/s00392-023-02345-7","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,11]]},"assertion":[{"value":"21 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"BT receives project-related funding from the German Foundation of Heart Research and Werner Otto Stiftung outside the submitted work. BT and JL share a project-related grant by the Ernst und Berta Grimmke-Stiftung. PH has received travel grants from the German Center for Cardiovascular Research (DZHK e.V.) and is supported by a grant from the Faculty of Medicine, University of Hamburg, as well as by the German Foundation of Heart Research. MK received consulting fees and honoraria from Adrenomed, Pharmacosmos, 4TEEN4, Sphingotec and Vifor Pharma. He further received grant support from Else Kroener-Fresenius foundation, German Research Foundation, European Union (Horizon 2020), Federal Ministry of Education and Research, German Center for Cardiovascular Research (DZHK e.V.), and Vifor Pharma. TZ is supported by the German Research Foundation, the EU Horizon 2020 programme, the EU ERANet and ERAPreMed Programmes, the German Center for Cardiovascular Research (DZHK e.V., 81Z0710102) and the German Ministry of Education and Research. RT reports research support from the German Center for Cardiovascular Research (DZHK e.V.), the K\u00fchne Foundation, the Joachim Herz Foundation, the Swiss National Science Foundation (Grant No P300PB_167803) and the Swiss Heart Foundation as well as speaker honoraria\/consulting honoraria from Abbott, Amgen, Astra Zeneca, Psyros, Roche, Siemens, Singulex and Thermo Scientific BRAHMS. NS receives funding by the German Heart Foundation and German Research Foundation, and reports speaker honoraria by Siemens Healthineers. DW has received honoraria from Abiomed, AstraZeneca, Bayer, Boehringer Ingelheim, Medtronic, and Novartis. JN reports honoraria from PHC, Roche and Siemens. JT, RT and TZ are listed as co-founders and shareholders of the ART-EMIS Hamburg GmbH, which holds an international patent application on the use of a computing device to estimate the probability of myocardial infarction (International Publication Numbers WO2022043229A1, TW202219980A). All other authors have reported that they have no competing risks to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the local ethics committee Hamburg (Ethikkomission der \u00c4rztekammer) and was conducted in accordance with the Declaration of Helsinki. All study participants provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}